SEC Comment Letter 0000000000-23-003048 to Vigil Neuroscience, Inc. (VIGL) (CIK 0001827087)
Vigil Neuroscience, Inc. (VIGL) (CIK 0001827087)
Date: March 27, 2023 · CIK: 0001827087 · Accession: 0000000000-23-003048
AI Filing Summary & Sentiment
File numbers found in text: 333-270710
Letter
United States securities and exchange commission logo March 27, 2023 Ivana Magovevi-Liebisch President and Chief Executive Officer Vigil Neuroscience, Inc. 100 Forge Road, Suite 700 Watertown, MA 02472 Re:Vigil Neuroscience, Inc. Registration Statement on Form S-3 Filed March 21, 2023 File No. 333-270710 Dear Ivana Magovevi-Liebisch: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gabriela Morales-Rivera, Esq.
Show Raw Text
United States securities and exchange commission logo
March 27, 2023
Ivana Magovevi-Liebisch
President and Chief Executive Officer
Vigil Neuroscience, Inc.
100 Forge Road, Suite 700
Watertown, MA 02472
Re:Vigil Neuroscience, Inc.
Registration Statement on Form S-3
Filed March 21, 2023
File No. 333-270710
Dear Ivana Magovevi-Liebisch:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Gabriela Morales-Rivera, Esq.